Deals
Echo Therapeutics Raises $3M at 43% Premium via Newbridge Securities Corporation
|
Echo Therapeutics (NASDAQ CM:ECTE) announced that it has raised $3,358,000 in a Convertible Secured Notes transaction.
Growth Capitalist (https://growthcapitalist.com/category/premium-articles/deals/page/54/)
Recent growth capital transactions by pre-IPO private and public emerging growth companies
Echo Therapeutics (NASDAQ CM:ECTE) announced that it has raised $3,358,000 in a Convertible Secured Notes transaction.
Differential Brands Group (NASDAQ CM:DFBG) announced that it has raised $50,000,000 in a Convertible Preferred Stock transaction.
ImmuCell Corporation (NASDAQ CM:ICCC) announced that it has raised $5,900,003 in a CMPO/Overnight transaction.
Amarantus BioScience (OTC:AMBS) announced that it has raised $1,000,000 in a Convertible Preferred Stock transaction.